These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4965252)

  • 1. Inhibition of haemaggregation by lepromin and other mycobacterial substances.
    Goodwin CS; Tyrrell DA; Head B; Rees RJ
    Nature; 1967 Dec; 216(5119):1019-20. PubMed ID: 4965252
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative and qualitative studies of the local cellular exudative response in leprosy.
    Bullock WE; Ho MF; Chen MJ
    J Reticuloendothel Soc; 1974 Nov; 16(5):259-68. PubMed ID: 4613829
    [No Abstract]   [Full Text] [Related]  

  • 3. IMMUNOLOGICAL IDENTIFICATION OF FOOT-PAD ISOLATES AS MYCOBACTERIUM LEPRAE BY LEPROMIN REACTIVITY IN LEPROSY PATIENTS.
    SHEPARD CC; GUINTO RS
    J Exp Med; 1963 Aug; 118(2):195-204. PubMed ID: 14074384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response of the patient with leprosy toward Mycobacterium leprae injected with lepromin. A histopathologic study four hours after injection.
    Saúl A
    Int J Lepr Other Mycobact Dis; 1971; 39(2):300-7. PubMed ID: 4948077
    [No Abstract]   [Full Text] [Related]  

  • 5. Skin test response to M. leprae precursor coccoid organisms in a high leprosy endemic area as compared to lepromin.
    Chatterjee BR
    Lepr India; 1981 Oct; 53(4):566-79. PubMed ID: 7038299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
    Bapat CV; Modak MS; DeSouza NG; Chulawalla RG
    Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lepromin stimulates interleukin-2 production and interleukin-2 receptor expression in situ in lepromatous leprosy patients.
    Longley BJ; Haregewoin A; de Beaumount W; Smith KA; Godal T
    Lepr Rev; 1986 Dec; 57 Suppl 2():189-98. PubMed ID: 3106736
    [No Abstract]   [Full Text] [Related]  

  • 8. Impairment of reactivity to lepromin by mycobacterial antigens related to, or identical with, Mycobacterium leprae.
    Kwapinski JB; Bechelli LM; Haddad N; Simao ET
    Can J Microbiol; 1975 Jun; 21(6):896-901. PubMed ID: 1097072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the Mitsuda reaction to Mycobacterium leprae can be mediated by lymphocytes responsive to Mycobacterium tuberculosis.
    Roberts PP; Dockrell HM; McAdam KP
    Clin Exp Immunol; 1988 Jun; 72(3):390-3. PubMed ID: 2458870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on lepromin and soluble antigens of M.leprae: their classification standardization and use.
    Sengupta U
    Indian J Lepr; 1991; 63(3-4):457-65. PubMed ID: 1804898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative cross reactivity of habanin, lepromin and tuberculin in guinea pigs sensitized with homologous and heterologous mycobacteria.
    Singh NB; Srivastava A; Gupta HP; Kumar A; Chaturvedi VK
    Indian J Lepr; 1988 Jul; 60(3):407-12. PubMed ID: 3143770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucocyte migration inhibition response of Mycobacterium habana with sensitized animals and cells from leprosy patients.
    Singh NB; Gupta HP; Mathur IS; Kumar A; Chakraborty SK
    Indian J Lepr; 1985; 57(2):273-7. PubMed ID: 3935726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Mycobacterium leprae-induced leucocyte migration inhibition following lepromin injection in healthy contacts of leprosy. Preliminary observations.
    Rao SS; Stanley JN; Pearson JM
    Lepr Rev; 1985 Dec; 56(4):291-5. PubMed ID: 3908863
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of Mitsuda reaction to nude mouse and armadillo lepromin preparations using nine-banded armadillos.
    Job CK; Truman RW
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):18-22. PubMed ID: 10834065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal tests with mycobacterial substances and normal tissue suspensions.
    Leiker DL
    Int J Lepr Other Mycobact Dis; 1968; 36(1):52-9. PubMed ID: 4869695
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation.
    Bjune G
    Int J Lepr Other Mycobact Dis; 1978; 46(3-4):386-93. PubMed ID: 83309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the antigenic specificity of Mycobacterium leprae. II. Purification and immunological characterization of the soluble antigen in leprosy nodules.
    Abe M; Minagawa F; Yoshino Y; Okamura K
    Int J Lepr Other Mycobact Dis; 1972; 40(2):107-17. PubMed ID: 4119113
    [No Abstract]   [Full Text] [Related]  

  • 18. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
    Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to antigens from cultivable saprophytic mycobacteria.
    Sharma RC; Singh R
    Lepr India; 1978 Oct; 50(4):572-8. PubMed ID: 374876
    [No Abstract]   [Full Text] [Related]  

  • 20. THE CONCENTRATION OF M. LEPRAE IN CURRENTLY AVAILABLE LEPROMINS.
    LECHAT MF; HANKS JH
    Int J Lepr; 1963; 31():348-52. PubMed ID: 14132394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.